In breast cancer, cervical cancer, colorectal cancer, glioma and papillary thyroid cancer, the expression of EDN3 gene is significantly down-regulated, which may be regulated by epigenetics (21, 23–26, 44, 45). This evidence concerns the gene EDN3 and breast carcinoma.